CRVO
CervoMed Inc.
2.50$
-0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | |
| 117.4% | 114.6% | 119.9% | 244.6% | 264.2% | 327.8% | 252.4% | – | – | – | – | – | – | |
| -17.4% | -14.7% | -19.9% | 100.0% | -164.2% | -227.8% | -152.3% | -190.6% | 100.0% | – | – | – | – | |
| 117.4% | 114.6% | 119.9% | 114.7% | 264.2% | 327.8% | 252.4% | 290.6% | 1,872.6% | 66,814.2% | – | – | 6,437.7% | |
| 157.9% | 84.9% | 90.7% | 76.4% | 114.0% | 107.1% | 124.3% | 185.8% | 721.2% | 28,765.0% | – | – | 3,069.2% | |
| 175.3% | 99.6% | 110.6% | 91.1% | 278.2% | 334.9% | 276.6% | 376.4% | 2,593.8% | 95,479.2% | – | – | 9,504.3% | |
| -175.3% | -99.6% | -110.6% | -91.1% | -278.2% | -334.9% | -276.6% | -376.4% | -2,493.8% | -95,479.2% | – | – | -9,407.0% | |
| 140.9% | -94.8% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% | |
| -175.3% | 32.1% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 140.9% | -94.8% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% | |
| 140.9% | 126.9% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.